Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Y-mAbs Therapeutics, Inc. Income Statement Banner

Y-mAbs Therapeutics, Inc. Income Statement

YMAB Stock Analysis

Page title

Section title

Breakdown
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
0.0000.0000.0000.00020.750M34.897M65.267M84.819M
Cost of Revenue
0.0000.00029.000K166.000K2.203M2.514M7.567M11.416M
Gross Profit
0.0000.000-29.000k-166.000k18.547M32.383M57.700M73.403M
Operating Expense
17.039M19.244M43.230M83.004M138.482M147.816M152.511M94.593M
Operating Income
-17.039m-19.244m-43.230m-83.004m-119.935m-115.433m-94.811m-21.190m
Other Income Expense
-18.000k83.000K-44.000k0.000-2.203m62.010M0.0000.000
Total Other Income Expense
-18.000k83.000K-44.000k1.976M598.000K60.158M-757.000k324.000K
Pretax Income
-17.057m-19.161m-43.274m-81.028m-119.337m-55.275m-95.568m-20.866m
Tax Provision
-17.039m-19.244m-44.000k-2.142m-994.000k1.070M757.000K561.000K
Net Income
-17.057m-19.161m-43.274m-78.886m-118.343m-56.345m-96.325m-21.427m
Basic EPS
-0.510-0.580-1.500-2.240-2.950-1.300-2.200-0.490
Diluted EPS
-0.510-0.580-1.500-2.240-2.950-1.300-2.200-0.490
Basic Average Shares
33.294M33.294M28.772M35.183M40.119M43.182M43.704M43.645M
Diluted Average Shares
33.294M33.294M28.772M35.183M40.119M43.182M43.704M43.645M
Total Expenses
17.039M19.244M43.230M83.004M138.482M150.330M160.078M106.009M
Interest Income
0.0000.0000.0001.976M598.000K1.852M643.000K0.000
Interest Expense
0.0000.000-44.000k1.976M598.000K1.852M757.000K0.000
EBITDA
-17.039m-19.244m-43.230m-83.004m-117.732m-115.433m-94.811m-20.455m
Depreciation & Amortization
17.039M19.244M29.000K166.000K396.000K782.000K839.000K735.000K